Skip to content

Feasibility and preliminary effectiveness study of an intensive short-term treatment program for eating disorders

Feasibility and preliminary effectiveness study of an outpatient intensive short-term treatment program using EMDR and in vivo exposure for adolescents and young adults aged 16-25 with an eating disorder - Feasibility and preliminary effectiveness of IST-ED

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON61225
Enrollment
30
Registered
2025-12-11
Start date
2026-09-01
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eating disorders Eating disorders

Interventions

Intensive Short-term Treatment-Eating Disorders (IST-ED), an intensive intervention combining EMDR and in vivo exposure as an add-on to treatment as usual.

Sponsors

GGZ Noord-Holland-Noord
Lead Sponsor

Eligibility

Age
12 Years to 64 Years

Inclusion criteria

Inclusion criteria: •    Aged between 16 and 25 years. •    Meet the diagnostic criteria for one of the following eating disorders as defined by the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5; American Psychiatric Association, 2013): o    Anorexia nervosa o    Bulimia nervosa o    Binge eating disorder o    Other specified feeding or eating disorders (OSFED) o    Unspecified feeding or eating disorders •    Sufficient proficiency in the Dutch language to complete the questionnaires. •    Willing and able to provide informed consent.  

Exclusion criteria

Exclusion criteria: Participants will be excluded if they meet any of the following criteria:Presence of acute psychotic symptoms that impede treatment.Current substance use, as identified by the referring clinician.Insufficient proficiency in the Dutch language to participate meaningfully in treatment and assessments.A comorbid diagnosis of post-traumatic stress disorder (PTSD). The presence of PTSD will be assessed using the Clinician-Administered PTSD Scale (CAPS; Boeschoten et al., 2018). This exclusion is based on the following considerations:Recommendations from the multidisciplinary PTSD guidelines (Trimbos Institute, 2017), which advise prioritizing PTSD treatment when comorbid conditions are present.The limited number of treatment sessions available within the IST-ED program; additional Eye Movement Desensitization and Reprocessing (EMDR) sessions are typically required in cases of comorbid PTSD.The need to maintain clarity and consistency in research outcomes, as this study specifically focuses on treatment effects on eating disorder symptoms and maintaining factors.  

Design outcomes

Primary

MeasureTime frame
Feasibility (i.e. dropout rate under 30%), client satisfaction, (CSQ-8)

Secondary

MeasureTime frame
Changes in quality of life (WHOQOL-BREF), and preliminary effectiveness in eating disorder symptoms (EDE-Q), clinical perfectionism (EDI-3 Perfectionism subscale), negative body attitude (LAV), self-esteem (RSES), and distress related to upsetting memories (PCL-5). The moderating effects of illness duration and treatment motivation on treatment outcomes will be examined.

Countries

Netherlands

Contacts

Public ContactD Sol

GGZ Noord-Holland-Noord

d.sol@ggz-nhn.nl0647054681

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 21, 2026